Literature DB >> 20014070

SAFB1's multiple functions in biological control-lots still to be done!

Jason P Garee1, Steffi Oesterreich.   

Abstract

The examination of scaffold attachment factor B1 (SAFB1) and its multiple functions and tasks in cellular processes provides insight into its role in diseases, such as cancer. SAFB1 is a large multi-domain protein with well-described functions in transcriptional repression, and RNA splicing. It is ubiquitously expressed, and has been shown to be important in numerous cellular processes including cell growth, stress response, and apoptosis. SAFB1 is part of a protein family with at least two other family members, SAFB2 and the SAFB-like transcriptional modulator SLTM. The goal of this prospect article is to summarize known functions of SAFB1, and its roles in cellular processes, but also to speculate on less well described, novel attributes of SAFB1, such as a potential role in chromatin organization. This timely review shows aspects of SAFB1, which are proving to have a complexity far greater than was previously thought. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20014070     DOI: 10.1002/jcb.22420

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  22 in total

1.  Lifespan Extension in C. elegans Caused by Bacterial Colonization of the Intestine and Subsequent Activation of an Innate Immune Response.

Authors:  Sandeep Kumar; Brian M Egan; Zuzana Kocsisova; Daniel L Schneider; John T Murphy; Abhinav Diwan; Kerry Kornfeld
Journal:  Dev Cell       Date:  2019-04-08       Impact factor: 12.270

2.  Scaffold attachment factor B suppresses HIV-1 infection of CD4+ T cells by preventing binding of RNA polymerase II to HIV-1's long terminal repeat.

Authors:  Li Ma; Li Sun; Xia Jin; Si-Dong Xiong; Jian-Hua Wang
Journal:  J Biol Chem       Date:  2018-06-10       Impact factor: 5.157

3.  Role of nuclear architecture in epigenetic alterations in cancer.

Authors:  H P Easwaran; S B Baylin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-03-29

4.  Eight-plex iTRAQ labeling and quantitative proteomic analysis for human bladder cancer.

Authors:  Qimin Zhang; Shengsong Huang; Huarong Luo; Xin Zhao; Gang Wu; Denglong Wu
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

5.  Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43.

Authors:  Rodrigo A Fuentealba; Maria Udan; Shaughn Bell; Iga Wegorzewska; Jieya Shao; Marc I Diamond; Conrad C Weihl; Robert H Baloh
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

6.  A proteomic approach identifies SAFB-like transcription modulator (SLTM) as a bidirectional regulator of GLI family zinc finger transcription factors.

Authors:  Zilai Zhang; Xiaoming Zhan; Bongwoo Kim; Jiang Wu
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

7.  Co-repressor activity of scaffold attachment factor B1 requires sumoylation.

Authors:  Jason P Garee; Rene Meyer; Steffi Oesterreich
Journal:  Biochem Biophys Res Commun       Date:  2011-04-19       Impact factor: 3.575

8.  Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma.

Authors:  Masato Tsuchiya; Joel S Parker; Hiroshi Kono; Masanori Matsuda; Hideki Fujii; Ivan Rusyn
Journal:  Mol Cancer       Date:  2010-04-09       Impact factor: 27.401

9.  Subcellular dynamics of estrogen-related receptors involved in transrepression through interactions with scaffold attachment factor B1.

Authors:  Takashi Tanida; Ken Ichi Matsuda; Taisuke Uemura; Takeshi Yamaguchi; Takashi Hashimoto; Mitsuhiro Kawata; Masaki Tanaka
Journal:  Histochem Cell Biol       Date:  2021-06-15       Impact factor: 4.304

10.  Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2.

Authors:  N K Mukhopadhyay; J Kim; S You; M Morello; M H Hager; W-C Huang; A Ramachandran; J Yang; B Cinar; M A Rubin; R M Adam; S Oesterreich; D Di Vizio; M R Freeman
Journal:  Oncogene       Date:  2013-07-29       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.